A Long Non-Coding RNA snaR Contributes to 5-Fluorouracil Resistance in Human Colon Cancer Cells

Molecules and Cells

Volumn 37, Issue 7, 2014, Pages 540-546

  Lee, Heejin ^a   Kim, Chongtae ^a   Ku, Ja Lok ^b   Kim, Wook ^c   Yoon, Sungjoo Kim ^a,d   Kuh, Hyo Jeong ^a,d   Lee, Jeong Hwa ^a,d   Nam, Suk Woo ^a,d   Lee, Eun Kyung ^a,d  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b Seoul National University Graduate School   (South Korea)

^c Ajou University   (South Korea)

^d The Catholic University of Korea   (South Korea)

Author keywords

5 Fluorouracil; cell viability; drug resistance; long non coding RNAs; snaR

Indexed keywords

BACE1-AS LONG NON-CODING RNA, HUMAN; FLUOROURACIL; LONG UNTRANSLATED RNA; SMALL INTERFERING RNA; TRANSCRIPTOME;

CELL CYCLE; CELL DEATH; CELL GROWTH; CELL SURVIVAL; COLONIC NEOPLASMS; DOWN REGULATION; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; HUMAN; IMMUNOLOGY; TUMOR CELL LINE;

CELL CYCLE; CELL DEATH; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; HUMANS; RNA, LONG NONCODING; RNA, SMALL INTERFERING; TRANSCRIPTOME;

EID: 84928997641     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.14348/molcells.2014.0151     Document Type: Article

References (48)

1. Batista, P.J., Chang, H.Y., Long noncoding RNAs: cellular address codes in development and disease. Cell 152 (2013), 1298–1307.
2. Boyer, J., Allen, W.L., McLean, E.G., Wilson, P.M., McCulla, A., Moore, S., Longley, D.B., Caldas, C., Johnston, P.G., Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer. Cancer Res 66 (2006), 2765–2777.
3. Choi, C.H., Lee, T.B., Lee, Y.A., Choi, S., Kim, K.J., Upregulation of cyclooxygenase-2-derived prostaglandin E(2) in colon cancer cells resistant to 5-fluorouracil. J Korean Surg Soc 81 (2011), 115–121.
4. Djebali, S., Davis, C.A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F., Landscape of transcription in human cells. Nature 489 (2012), 101–108.
5. Esteller, M., Non-coding RNAs in human disease. Nat Rev Genet 12 (2011), 861–874.
6. Fan, Y., Shen, B., Tan, M., Mu, X., Qin, Y., Zhang, F., Liu, Y., Long non-coding RNA UCA1 increases chemoresistances of bladder cancer cells by regulating Wnt signaling. FEBS J 281 (2014), 1750–1758.
7. Fatica, A., Bozzoni, I., Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet 15 (2013), 7–21.
8. Fojo, T., Multiple paths to a drug resistance phenotype: mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs. Drug Resist Updat 10 (2007), 59–67.
9. Fulda, S., Susin, S.A., Kroemer, G., Debatin, K.M., Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells. Cancer Res 58 (1998), 4453–4460.
10. Ganguly, A., Banerjee, K., Chakraborty, P., Das, S., Sarkar, A., Hazra, A., Banerjee, M., Maity, A., Chatterjee, M., Mondal, N.B., Overcoming multidrug resistance (MDR) in cancer in virto and in vivo by a quinoline derivative. Biomed Pharmacother 65 (2011), 387–394.
11. Gibb, E.A., Brown, C.J., Lam, W.L., The functional role of long non-coding RNA in human carcinomas. Mol Cancer, 10, 2011, 38.
12. Glasspool, R.M., Teodoridis, J.M., Brown, R., Epigenetics as a mechanism driving polygenic clinical drug resistance. Br J Cancer 94 (2006), 1087–1092.
13. Gottesman, M.M., Mechanisms of cancer drug resistance. Ann Rev Med 53 (2002), 615–627.
14. Grem, J.L., 5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development. Invest New Drugs 18 (2000), 299–313.
15. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators (1995). Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 345, 939-944.
16. Jung, G.R., Kim, K.J., Choi, C.H., Lee, T.B., Han, S.I., Han, H.K., Lim, S.C., Effect of betulinic acid on anticancer drug-resistant colon cancer cells. Basic Clin Pharmacol Toxicol 101 (2007), 277–285.
17. Kang, H., Kim, C., Lee, H., Kim, W., Lee, E.K., Post-transcriptional controls by ribonucleoprotein complexes in the acquisition of drug resistance. Int J Mol Sci 14 (2013), 17204–17220.
18. Karasawa, H., Miura, K., Fujibuchi, W., Ishida, K., Kaneko, N., Kinouchi, M., Okabe, M., Ando, T., Murata, Y., Sasaki, H., Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells. Cancer Sci 100 (2009), 903–913.
19. Kurokawa, K., Tanahashi, T., Iima, T., Yamamoto, Y., Akaike, Y., Nishida, K., Masuda, K., Kuwano, Y., Murakami, Y., Fukushima, M., Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells. J Gastroenterol 47 (2012), 883–895.
20. Liu, Z., Sun, M., Lu, K., Liu, J., Zhang, M., Wu, W., De, W., Wang, Z., Wang, R., The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21(WAF1/CIP1) expression. PLoS One, 8, 2013, e77293.
21. Ma, J., Dong, C., Ji, C., MicroRNA and drug resistance. Cancer Gene Ther 17 (2010), 523–531.
22. Mariadason, J.M., Arango, D., Shi, Q., Wilson, A.J., Corner, G.A., Nicholas, C., Aranes, M.J., Lesser, M., Schwartz, E.L., Augenlicht, L.H., Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin. Cancer Res 63 (2003), 8791–8812.
23. Mercer, T.R., Dinger, M.E., Mattick, J.S., Long non-coding RNAs: insights into functions. Nat Rev Genet 10 (2009), 155–159.
24. Mishra, P.J., The miRNA-drug resistance connection: a new era of personalized medicine using noncoding RNA begins. Pharmacogenomics 13 (2012), 1321–1324.
25. Mishra, P.J., Bertino, J.R., MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. Pharmacogenomics 10 (2009), 399–416.
26. Oh, J.H., Ku, J.L., Yoon, K.A., Kwon, H.J., Kim, W.H., Park, H.S., Yeo, K.S., Song, S.Y., Chung, J.K., Park, J.G., Establishment and characterization of 12 human colorectal-carcinoma cell lines. International journal of cancer. J Int Cancer 81 (1999), 902–910.
27. Ooyama, A., Takechi, T., Toda, E., Nagase, H., Okayama, Y., Kitazato, K., Sugimoto, Y., Oka, T., Fukushima, M., Gene expression analysis using human cancer xenografts to identify novel predictive marker genes for the efficacy of 5-fluorouracil-based drugs. Cancer Sci 97 (2006), 510–522.
28. Park, J.G., Oie, H.K., Sugarbaker, P.H., Henslee, J.G., Chen, T.R., Johnson, B.E., Gazdar, A., Characteristics of cell lines established from human colorectal carcinoma. Cancer Res 47 (1987), 6710–6718.
29. Parrott, A.M., Mathews, M.B., Novel rapidly evolving hominid RNAs bind nuclear factor 90 and display tissue-restricted distribution. Nucleic Acids Res 35 (2007), 6249–6258.
30. Parrott, A.M., Mathews, M.B., snaR genes: recent descendants of Alu involved in the evolution of chorionic gonadotropins. Cold Spring Harbor Symp Quant Biol 74 (2009), 363–373.
31. Parrott, A.M., Tsai, M., Batchu, P., Ryan, K., Ozer, H.L., Tian, B., Mathews, M.B., The evolution and expression of the snaR family of small non-coding RNAs. Nucleic Acids Res 39 (2011), 1485–1500.
32. Peters, G.J., Backus, H.H., Freemantle, S., van Triest, B., Codacci-Pisanelli, G., van der Wilt, C.L., Smid, K., Lunec, J., Calvert, A.H., Marsh, S., Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim Biophys Acta 1587 (2002), 194–205.
33. Raguz, S., Yague, E., Resistance to chemotherapy: new treatments and novel insights into an old problem. Br J Cancer 99 (2008), 387–391.
34. Rinn, J.L., Chang, H.Y., Genome regulation by long noncoding RNAs. Ann Rev Biochem 81 (2012), 145–166.
35. Roberti, A., La Sala, D., Cinti, C., Multiple genetic and epigenetic interacting mechanisms contribute to clonally selection of drug-resistant tumors: current views and new therapeutic prospective. J Cell Physiol 207 (2006), 571–581.
36. Rukov, J.L., Shomron, N., MicroRNA pharmacogenomics: post-transcriptional regulation of drug response. Trends Mol Med 17 (2011), 412–423.
37. Shin, Y.K., Yoo, B.C., Chang, H.J., Jeon, E., Hong, S.H., Jung, M.S., Lim, S.J., Park, J.G., Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance. Cancer Res 65 (2005), 3162–3170.
38. Shin, Y.K., Yoo, B.C., Hong, Y.S., Chang, H.J., Jung, K.H., Jeong, S.Y., Park, J.G., Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5-fluorouracil resistance. Electrophoresis 30 (2009), 2182–2192.
39. Strathdee, G., Epigenetic markers and response to chemotherapy in cancer. Dis Markers 23 (2007), 43–49.
40. Taft, R.J., Pang, K.C., Mercer, T.R., Dinger, M., Mattick, J.S., Non-coding RNAs: regulators of disease. J Pathol 220 (2010), 126–139.
41. Tan, D.S., Gerlinger, M., Teh, B.T., Swanton, C., Anticancer drug resistance: understanding the mechanisms through the use of integrative genomics and functional RNA interference. Eur J Cancer 46 (2010), 2166–2177.
42. Wang, K.C., Chang, H.Y., Molecular mechanisms of long noncoding RNAs. Mol Cell 43 (2011), 904–914.
43. Wang, Z., Li, Y., Ahmad, A., Azmi, A.S., Kong, D., Banerjee, S., Sarkar, F.H., Targeting miRNAs involved in cancer stem cell and EMT regulation: an emerging concept in overcoming drug resistance. Drug Resist Updat 13 (2010), 109–118.
44. Whitehead, J., Pandey, G.K., Kanduri, C., Regulation of the mammalian epigenome by long noncoding RNAs. Biochim Biophys Acta 1790 (2009), 936–947.
45. Wilusz, J.E., Sunwoo, H., Spector, D.L., Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 23 (2009), 1494–1504.
46. Xu, X., Chen, H., Lin, Y., Hu, Z., Mao, Y., Wu, J., Xu, X., Zhu, Y., Li, S., Zheng, X., MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met. Mol Cells 36 (2013), 62–68.
47. Zhang, N., Yin, Y., Xu, S.J., Chen, W.S., 5-Fluorouracil: mechanisms of resistance and reversal strategies. Molecules 13 (2008), 1551–1569.
48. Zheng, T., Wang, J., Chen, X., Liu, L., Role of micro-RNA in anticancer drug resistance. Int J Cancer 126 (2010), 2–10.